HLAVATÝ, Tibor et al. Relapse rates of inflammatory bowel disease patients in deep and clinical remission after discontinuing anti-tumor necrosis factor alpha therapy. In Bratislavské lekárske listy, 2016, vol. 117, no. 4, s. 205-211. ISSN 0006-9248. Bratislava : AEPress, 2016.